ZKSCAN3 and cervical carcinoma: Clinical studies further showed that high expression of ZKSCAN3 was significantly associated with shorter OS and higher risk of disease recurrence in patients, and its high expression in patients with low-grade cervical cancer was associated with worse progression-free survival (PFS) and OS, suggesting that it could be used as an independent prognostic indicator [5,76].